Patents by Inventor Jeff Boissier

Jeff Boissier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11957888
    Abstract: A method may include displaying at least three icons on a user interface of a mobile device, including a first icon associated with the at least three icons associated with a first carbohydrate level, a second icon associated with the at least three icons associated with a second carbohydrate level, and a third icon associated with the at least three icons associated with a third carbohydrate level. The method may also include receiving a user selection of one of the three icons through the user interface of the mobile device, and determining an insulin bolus level from the user selection. The method may also include communicating the insulin bolus level to an insulin delivery device.
    Type: Grant
    Filed: January 11, 2022
    Date of Patent: April 16, 2024
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Lane Desborough, Bryan Mazlish, Andrew Bochenko, Ross Naylor, Jeff Boissier, Sabine Kabel-Eckes
  • Patent number: 11389088
    Abstract: A method of displaying blood glucose information may include monitoring blood glucose levels of a user, where the blood glucose levels include at least a current blood glucose level and a historic blood glucose level. The method may also include presenting the current blood glucose level using a point indicator along an approximately horizontally centered axis based on a non-linear scale, and presenting the historic blood glucose level and a predicted future blood glucose level on the display as a single smoothed curve passing the point indicator.
    Type: Grant
    Filed: July 13, 2018
    Date of Patent: July 19, 2022
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Lane Desborough, Bryan Mazlish, Sabine Kabel-Eckes, Jeff Boissier
  • Publication number: 20220134017
    Abstract: A method may include displaying at least three icons on a user interface of a mobile device, including a first icon associated with the at least three icons associated with a first carbohydrate level, a second icon associated with the at least three icons associated with a second carbohydrate level, and a third icon associated with the at least three icons associated with a third carbohydrate level. The method may also include receiving a user selection of one of the three icons through the user interface of the mobile device, and determining an insulin bolus level from the user selection. The method may also include communicating the insulin bolus level to an insulin delivery device.
    Type: Application
    Filed: January 11, 2022
    Publication date: May 5, 2022
    Inventors: Lane Desborough, Bryan Mazlish, Andrew Bochenko, Ross Naylor, Jeff Boissier, Sabine Kabel-Eckes
  • Patent number: 11229751
    Abstract: A method may include displaying at least three icons on a user interface of a mobile device, including a first icon associated with the at least three icons associated with a first carbohydrate level, a second icon associated with the at least three icons associated with a second carbohydrate level, and a third icon associated with the at least three icons associated with a third carbohydrate level. The method may also include receiving a user selection of one of the three icons through the user interface of the mobile device, and determining an insulin bolus level from the user selection. The method may also include communicating the insulin bolus level to an insulin delivery device.
    Type: Grant
    Filed: September 27, 2017
    Date of Patent: January 25, 2022
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Lane Desborough, Bryan Mazlish, Andrew Bochenko, Ross Naylor, Jeff Boissier, Sabine Kabel-Eckes
  • Publication number: 20210401367
    Abstract: Systems, methods, and devices provide alarms and alerts in an on-body networked diabetes management system. Methods may include receiving glucose sensor data from a continuous glucose monitor and determining a dosage of insulin delivery based at least in part on the glucose sensor data. The method may include detecting an alarm or alert condition, and sending a wireless communication regarding the alarm or alert condition to a remote user-interface device. The method may include triggering an audible, visual, or haptic alarm or alert on the insulin delivery device unless an acknowledgement of the alarm or alert condition is received within a predetermined period of time.
    Type: Application
    Filed: July 29, 2021
    Publication date: December 30, 2021
    Inventors: Bryan Mazlish, Sabine Kabel-Eckes, Shannon Sieber, Jeff Boissier, George Crothall, Yean Wah Chan
  • Patent number: 11096624
    Abstract: Systems, methods, and devices provide alarms and alerts in an on-body networked diabetes management system. Methods may include receiving glucose sensor data from a continuous glucose monitor and determining a dosage of insulin delivery based at least in part on the glucose sensor data. The method may include detecting an alarm or alert condition, and sending a wireless communication regarding the alarm or alert condition to a remote user-interface device. The method may include triggering an audible, visual, or haptic alarm or alert on the insulin delivery device unless an acknowledgement of the alarm or alert condition is received within a predetermined period of time.
    Type: Grant
    Filed: December 12, 2017
    Date of Patent: August 24, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Bryan Mazlish, Sabine Kabel-Eckes, Shannon Sieber, Jeff Boissier, George Crothall, Yean Wah Chan
  • Publication number: 20190385752
    Abstract: A computer-implemented method for automated provisioning of clinical advice to a provider caring for a patient with diabetes (PWD). The method includes detecting a clinically relevant pattern in therapy data of a patient under the care of a provider, and identifying a predefined behavior of a PWD responsive to the detected clinically relevant pattern. The clinically relevant detected pattern is indicative of desirable behaviors and/or undesirable behaviors. The method further includes selecting a therapy insight associated with the identified predefined behavior, wherein the therapy insight comprises clinical advice associated with the PWD that includes a behavior recommendation, and responsive to the selecting the therapy insight, automatically sending, to a provider-dashboard associated with the provider caring for the PWD, the selected therapy insight.
    Type: Application
    Filed: June 14, 2019
    Publication date: December 19, 2019
    Inventors: Jacob Bowland, Bethany Leigh Salmon, Jennifer Martin Block, Alex Constantin, Sabine Kabel-Eckes, Jeff Boissier
  • Publication number: 20190385721
    Abstract: A method for receiving insulin therapy information related to insulin-based management of person with diabetes (PWD) at a provider-dashboard associated with a provider caring for the PWD. The method includes displaying, on the display, a therapy insight, at a provider-dashboard associated with a provider caring for a PWD. The therapy insight comprises clinical advice for insulin-based management of the person's diabetes. The method further includes receiving insulin therapy information related to insulin-based management of the person's diabetes provided at the provider-dashboard, and updating the therapy insight to include the insulin therapy information.
    Type: Application
    Filed: June 14, 2019
    Publication date: December 19, 2019
    Inventors: Jacob Bowland, Bethany Leigh Salmon, Jennifer Martin Block, Alexandra Elena Constantin, Sabine Kabel-Eckes, Jeff Boissier
  • Publication number: 20190385728
    Abstract: A method for presenting insulin therapy setting recommendations associated with a therapy insight for a person with diabetes (PWD) at an electronic device. The method includes, at a device with one or more processors, memory, and a display, displaying on a dashboard of a PWD, at the display a first layer. The first layer includes a therapy insight corresponding to a PWD. The therapy insight generated based in part on insulin therapy data of the PWD. The therapy insight corresponds to insulin therapy of the PWD. The therapy insight comprises clinical advice for insulin-based management of PWDs diabetes. The first layer also includes an insulin therapy recommendation associated with the therapy insight. The insulin therapy recommendation corresponds to a pattern of behavior associated with the insulin-based management of the PWDs diabetes wherein the first layer overlays at least a portion of a second layer. The first layer overlays at least a portion of a second layer.
    Type: Application
    Filed: June 14, 2019
    Publication date: December 19, 2019
    Inventors: Jacob Bowland, Bethany Leigh Salmon, Jennifer Martin Block, Alexandra Elena Constantin, Sabine Kabel-Eckes, Jeff Boissier
  • Publication number: 20190381243
    Abstract: A method for presenting therapy insights that includes pre-generated content at an electronic device. The method comprising, at a device with one or more processors, memory and a display, displaying, on the display, and insulin therapy data. The therapy insight corresponding to a person with diabetes (PWD). The therapy insight generated based in part on the insulin therapy data of the PWD. The therapy insight includes pre-generated content. The pre-generated content includes clinical advice of insulin-based management of diabetes associated with the PWD.
    Type: Application
    Filed: June 14, 2019
    Publication date: December 19, 2019
    Inventors: Jacob Bowland, Bethany Leigh Salmon, Jennifer Martin Block, Alexandra Elena Constantin, Sabine Kabel-Eckes, Jeff Boissier
  • Publication number: 20190274624
    Abstract: Systems, methods, and devices provide alarms and alerts in an on-body networked diabetes management system. Methods may include receiving glucose sensor data from a continuous glucose monitor and determining a dosage of insulin delivery based at least in part on the glucose sensor data. The method may include detecting an alarm or alert condition, and sending a wireless communication regarding the alarm or alert condition to a remote user-interface device. The method may include triggering an audible, visual, or haptic alarm or alert on the insulin delivery device unless an acknowledgement of the alarm or alert condition is received within a predetermined period of time.
    Type: Application
    Filed: December 12, 2017
    Publication date: September 12, 2019
    Inventors: Bryan Mazlish, Sabine Kabel-Eckes, Shannon Sieber, Jeff Boissier, George Crothall, Yean Wah Chan
  • Publication number: 20190015025
    Abstract: A method of displaying blood glucose information may include monitoring blood glucose levels of a user, where the blood glucose levels include at least a current blood glucose level and a historic blood glucose level. The method may also include presenting the current blood glucose level using a point indicator along an approximately horizontally centered axis based on a non-linear scale, and presenting the historic blood glucose level and a predicted future blood glucose level on the display as a single smoothed curve passing the point indicator.
    Type: Application
    Filed: July 13, 2018
    Publication date: January 17, 2019
    Inventors: Lane Desborough, Bryan Mazlish, Sabine Kabel-Eckes, Jeff Boissier
  • Publication number: 20190015024
    Abstract: A system for displaying blood glucose information includes a blood glucose monitoring device configured to monitor blood glucose levels of a user, and a display. The system may also include one or more processors, and a non-transitory computer-readable medium containing instructions that, when executed by the one or more processors, cause the system to perform operations. The operations may include obtaining the blood glucose levels from the blood glucose monitoring device, where the blood glucose levels include at least a current blood glucose level and a historic blood glucose level. The operations may also include presenting the current blood glucose level at a first location on the display based on a first scale, and presenting the historic blood glucose level at a second location on the display based on a second scale different from the first scale.
    Type: Application
    Filed: July 13, 2018
    Publication date: January 17, 2019
    Applicants: Bigfoot Biomedical, Inc., Bigfoot Biomedical, Inc.
    Inventors: Lane Desborough, Bryan Mazlish, Sabine Kabel-Eckes, Jeff Boissier
  • Patent number: D836769
    Type: Grant
    Filed: December 12, 2016
    Date of Patent: December 25, 2018
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Sabine Kabel-Eckes, Charles R. Lewis, Jr., Shannon Sieber, Jeff Boissier, Bryan Mazlish, George Crothall
  • Patent number: D839294
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: January 29, 2019
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Bryan Mazlish, Sabine Kabel-Eckes, Shannon Sieber, Jeff Boissier
  • Patent number: D852837
    Type: Grant
    Filed: November 29, 2018
    Date of Patent: July 2, 2019
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Bryan Mazlish, Sabine Kabel-Eckes, Shannon Sieber, Jeff Boissier
  • Patent number: D863343
    Type: Grant
    Filed: September 27, 2017
    Date of Patent: October 15, 2019
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Bryan Mazlish, Jeff Boissier, Sabine Kabel-Eckes
  • Patent number: D911355
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: February 23, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Sabine Kabel-Eckes, Jeff Boissier, Jennifer Martin Block, Bryan Mazlish
  • Patent number: D928199
    Type: Grant
    Filed: April 2, 2018
    Date of Patent: August 17, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Bryan Mazlish, Sabine Kabel-Eckes, Jeff Boissier, Bethany Leigh Salmon
  • Patent number: D1020794
    Type: Grant
    Filed: May 25, 2021
    Date of Patent: April 2, 2024
    Assignee: BIGFOOT BIOMEDICAL, INC.
    Inventors: Bryan Mazlish, Sabine Kabel-Eckes, Jeff Boissier, Bethany Leigh Salmon